Original Article

Heart stiffing due to dilated cardiomyopathy in pediatric population and causes of its severity

Heart stiffing and dilated cardiomyopathy

Abstract

study was aimed to assess the possible changes in heart stiffing due to dilated cardiomyopathy and causes of severity in pediatric population.

Methods

Forty-eight children who had DCM and 96 healthy children were the subjects of this case-control study. The patients had an echocardiography determination of enlarged cardiomyopathy and healthy children were chosen randomly from the individuals who had alluded to the cardiac clinic for yearly examination. M-mode echocardiography was used to measure the ascending aorta's systolic and diastolic diameters, and modified Ross classification was used to classify heart failure. The Statistical Package for the Social Sciences, version 18 (SPSS, Chicago, USA), was used for statistical analysis. The level of statistical significance was set at p less than 0.05.

Results

 Of children 48 had DCM and 96 were healthy, were matched in gender (X2=0.014, p=0.905).  The parameters of EF (P<0.001), FS (P<0.001), IVSD (P<0.001), PWD (P<0.001), PWS (P<0.001), LVMI (P<0.001), RWT (P=0.009), AS (p=0.014). AD (p=0.004), ASBI (p=0.001) and PSEM (p=0.004) were different in groups significantly. After treatment, based on the EF and FS cutoffs none of elasticity parameters changed except ASβI that changed by ROSS classification.

Conclusion

Concluded that AS, AD decreased when ASBI and PSEM were increased in DCM children. EF, FS status and ROSS classifications were improved after treatment. The elasticity parameters preserved their status based on status of EF, FS and ROSS except ASβI that increased by changes in ROSS classification.

1. Loss KL, Shaddy RE, Kantor PF. Recent and Upcoming Drug Therapies for Pediatric Heart Failure. Front Pediatr. 2021 Nov 11;9:681224.
2. Bakeet MA, Mohamed MM, Allam AA, Gamal R. Childhood Cardiomyopathies: A Study in Tertiary Care Hospital in Upper Egypt. Electron Physician. 2016 Nov 25;8(11):3164-3169. doi: 10.19082/3164. PMID: 28070248; PMCID: PMC5217807.
3. Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Cox GF, Canter CE, Hsu DT, Webber SA, Lipshultz SE. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart failure clinics. 2010 Oct 1;6(4):401-13.
4. Oh JH, Hong YM, Choi JY, Kim SJ, Jung JW, Sohn S, et al. Idiopathic cardiomyopathies in Korean children. 9-Year Korean Multicenter Study. Circ J. 2011;75(9):2228–34. doi: 10.1253/circj.CJ-11-0051.
5. Sarohi V, Srivastava S, Basak T. A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches. Journal of Cardiovascular Development and Disease. 2022 Jun;9(6):174.
6. Hong YM. Cardiomyopathies in children. Korean J Pediatr. 2013;56(2):52–9. doi: 10.3345/kjp.2013.56.2.52.
7. Bonapace S, Rossi A, Cicoira M, Golia G, Zanolla L, Franceschini L, Conte L, Marino P, Zardini P, Vassanelli C. Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. American heart journal. 2006 Jul 1;152(1):93-e1.
8. Mathew, T.; Williams, L.; Navaratnam, G.; Rana, B.; Wheeler, R.; Collins, K.; Harkness, A.; Jones, R.; Knight, D.; O’Gallagher, K.; et al. Diagnosis and assessment of dilated cardio-myopathy: A guideline protocol from the British Society of Echocardiography. Echo Res. Pract. 2017, 4, G1–G13
9. Noori NM, Mahjoubifard M, Shahramian I, Teimouri A, Jahangirifard A. Comparison between procalcitonin, brain natriuretic peptide, and uric acid in children with cardiomyopathy and controls. Biomed Res Int. 2015;2015:510450.
10. Patrianakos AP, Parthenakis FI, Karakitsos D, Nyktari E, Vardas PE. Proximal aortic stiffness is related to left ventricular function and exercise capacity in patients with dilated cardiomyopathy. European Journal of Echocardiography. 2009 May 1;10(3):425-32.
11. Weber T. The Role of Arterial Stiffness and Central Hemodynamics in Heart Failure. Int J Heart Fail. 2020 Sep 23;2(4):209-230.
12. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019 May 9;5(1):32.
13. Patrianakos AP, Parthenakis FI, Nyktari E, Malliaraki N, Karakitsos DN, Vardas PE. Central aortic stiffness in patients with nonischemic dilated cardiomyopathy: relationship with neurohumoral activation. Journal of cardiac failure. 2009 Oct 1;15(8):665-72.
14. V.O. Puntmann, E. Arroyo Ucar, R. Hinojar Baydes, N.B. Ngah, Y.S. Kuo, D. Dabir, et al., Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy, Hypertension. 64 (4) (2014) 762–768.
15. Kaolawanich Y, Boonyasirinant T. Impact of aortic stiffness by velocity-encoded magnetic resonance imaging on late gadolinium enhancement to predict cardiovascular events. Int J Cardiol Heart Vasc. 2020 Sep 25;30:100635.
16. Chow B, Rabkin SW. The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart failure reviews. 2015 May;20(3):291-303
17. Seeland U, Brecht A, Nauman AT, Oertelt-Prigione S, Ruecke M, Knebel F, Stangl V, Regitz-Zagrosek V. Prevalence of arterial stiffness and the risk of myocardial diastolic dysfunction in women. Bioscience Reports. 2016 Oct 1;36(5).
18. Albu A, Fodor D, Bondor C, Poantă L. Arterial stiffness, carotid atherosclerosis and left ventricular diastolic dysfunction in postmenopausal women. European journal of internal medicine. 2013 Apr 1;24(3):250-4.
19. Karagodin, I., Aba-Omer, O., Sparapani, R. et al. Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction. BMC Cardiovasc Disord 17, 62 (2017). https://doi.org/10.1186/s12872-017-0490-9
20. Mitchell GF. Arterial stiffness in aging: does it have a place in clinical practice? Recent advances in hypertension. Hypertension. 2021;77(3):768-80.
21. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine reviews. 2004 Aug 1;25(4):543-67.
22. Borlaug BA, Kass DA. Ventricular-vascular interaction in heart failure. Cardiol Clin. 2011;29(3):447–59.
23. Mitchell GF. Aortic stiffness, pressure and flow pulsatility, and target organ damage. J Appl Physiol. 2018 ;125(6):1871-1880.
24. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection. Hypertension. 2010;56(4):555–62.
Files
IssueArticles In Press QRcode
SectionOriginal Article(s)
Keywords
Heart stiffing dilated cardiomyopathy pediatric

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Teimouri A, Noori NM. Heart stiffing due to dilated cardiomyopathy in pediatric population and causes of its severity. J Tehran Heart Cent. 2024;.